We want to help improve the lives and futures of children on the autism spectrum
Wolfgang Storf, CEO, Neurotech International Ltd.
We want to improve people’s lives by developing and commercialising innovative, high quality medical solutions for the diagnosis and treatment of brain-related disorders.
The AAT Research group of companies is a fully owned subsidiary of Neurotech International Limited, an Australian public company (ASX:NTI). We research, design, develop and manufacture quality medical solutions. With regulatory and quality systems in place and various international accreditations to our name, our purpose is to improve people’s lives though innovation in the field of neuroscience and medical technology. Our mission is to be a global leader in the field of neurophysiology by offering solutions suitable for home-use and clinics at affordable prices.
For further information on Neurotech International Ltd., please click here.
To improve the lives of people with neurological conditions.
To become a global leader in home-use and clinical neurotechnology solutions, which are accessible and affordable.
Our commitment to Quality
Commitment to the effectiveness of its QMS per regulatory requirements, whilst continuously improving the research and efficiency of its present and future medical devices.
To be team players, show care and compassion and to always communicate freely, clearly and respectfully.
To strive to achieve more than what is expected and to deliver what we promise without compromising quality or integrity.
To give highest priority to customer satisfaction and listen to customers and their needs.
To respect oneself and others, pushing for honesty, integrity and trust among colleagues.
MENTE HAS BEEN FEATURED BY